|
Palatin Technologies, Inc. Issued U.S. Patent for Key Component in PL-3994 …
PR Newswire (press release) A small molecule mimic claimed in the issued patent is used in making PL-3994, Palatin's lead peptide mimetic natriuretic peptide receptor A agonist, which is in development for treatment of acute exacerbations of asthma, heart failure and refractory … |
View full post on asthma – Google News